Dr Reddy's Laboratories was in focus on Friday's trading session after the pharma major launched Succinylcholine Chloride Injection USP in the strength of 200 mg/10 mL (20 mg/mL).
Succinylcholine Chloride injections which are available in Multiple-Dose Vials, a therapeutic equivalent generic version of Quelicin has been approved by the U.S. Food and Drug Administration (USFDA).
Dr Reddy's said the Quelicin brand and generic market had U.S. sales of approximately $74.8M MAT for the most recent twelve months ending in September 2020 according to IQVIA Health.
At around 1.31 PM, Dr Reddy's was trading at Rs4857 per piece up Rs30.25 or 0.63% on Sensex.
The stock has touched the day's high and low of Rs4883 per piece and Rs4827.95 per piece respectively.